These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1521898)
1. Failure of blood pressure to increase following erythropoietin therapy in the renoprival status. De Santo NG; Manzo M; Raiola P; Lanzetti N; Capasso G; Ficociello R; Anastasio P; Esposito R Int J Artif Organs; 1992 Mar; 15(3):144-6. PubMed ID: 1521898 [TBL] [Abstract][Full Text] [Related]
2. Relation between blood pressure and hematocrit in anephric patients treated by means of recombinant DNA human erythropoietin. Iorio L; Saltarelli G; Nacca RG; Violi F Nephron; 1996; 72(2):373-4. PubMed ID: 8684581 [No Abstract] [Full Text] [Related]
3. Angiotensin-converting enzyme inhibitor and anemia in a patient undergoing hemodialysis. Yoshida A; Morozumi K; Suganuma T; Aoki J; Sugito K; Nakamura S; Ikeda M; Oikawa T; Fujinami T; Kawahara H Nephron; 1991; 59(2):334-5. PubMed ID: 1956504 [No Abstract] [Full Text] [Related]
4. Progression of anemia and its relationship with renal function, blood pressure, and erythropoietin in rats with chronic kidney disease. Phillips JK; Boyd R; Krockenberger MB; Burgio G Vet Clin Pathol; 2015 Sep; 44(3):342-54. PubMed ID: 26292198 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients. Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091 [TBL] [Abstract][Full Text] [Related]
6. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics. Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294 [TBL] [Abstract][Full Text] [Related]
7. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure]. Schaefer RM; Heidland A Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190 [No Abstract] [Full Text] [Related]
8. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Bahlmann FH; Song R; Boehm SM; Mengel M; von Wasielewski R; Lindschau C; Kirsch T; de Groot K; Laudeley R; Niemczyk E; Güler F; Menne J; Haller H; Fliser D Circulation; 2004 Aug; 110(8):1006-12. PubMed ID: 15302785 [TBL] [Abstract][Full Text] [Related]
9. Early intervention with recombinant human erythropoietin therapy. Teehan BP; Benz RL; Sigler MH; Brown JM Semin Nephrol; 1990 Mar; 10(2 Suppl 1):28-34. PubMed ID: 2192414 [No Abstract] [Full Text] [Related]
10. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. Ifudu O; Feldman J; Friedman EA N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143 [TBL] [Abstract][Full Text] [Related]
11. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study]. Sinnassamy P; Andre JL; Treize G; Leroy B Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412 [TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients. Lebel M; Kingma I; Grose JH; Langlois S Am J Hypertens; 1995 Jun; 8(6):545-51. PubMed ID: 7662237 [TBL] [Abstract][Full Text] [Related]
13. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO). Campos A; Garin EH Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282 [TBL] [Abstract][Full Text] [Related]